e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Acute lung injury: novel clinical and experimental insights
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The GPx1-PTP1B-PP2A axis: A key determinant of airway inflammation and alveolar destruction
P. Geraghty, A. Hardigan, A. Wallace, O. Mirochnitchenko, J. Thankachen, J. D'Armiento, R. Foronjy (New York, Bethesda, United States Of America; Vancouver, Canada)
Source:
Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Session:
Acute lung injury: novel clinical and experimental insights
Session type:
Oral Presentation
Number:
1815
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Geraghty, A. Hardigan, A. Wallace, O. Mirochnitchenko, J. Thankachen, J. D'Armiento, R. Foronjy (New York, Bethesda, United States Of America; Vancouver, Canada). The GPx1-PTP1B-PP2A axis: A key determinant of airway inflammation and alveolar destruction. Eur Respir J 2013; 42: Suppl. 57, 1815
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Respiratory sequelae of preterm birth across the life span
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery
Related content which might interest you:
TSPO a new anti-inflammatory target in the airway of COPD
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015
A possible role of Krüppel-like factor 5 in small airway wall fibrosis in COPD
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015
IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Pro-and anti-fibrotic molecule balance in the bronchial mucosa of stable COPD patients
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD
Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases
Year: 2013
Inhibitors of apoptosis proteins in asthmatic airway inflammation
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
Regulation of GROα production in human bronchial epithelial cells
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
A role for WNT-5B in airway remodeling in COPD by activation of TGF-beta/Smad3 signaling?
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
The role of chemokine receptors in the aberrant migration of COPD neutrophils
Source: International Congress 2014 – Cell biology 2014
Year: 2014
The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Involvement of JNK in TNFα driven remodelling
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Myofibroblast expression in airways and alveoli is affected by smoking and COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Enhanced neutrophil extracellular trap (NET) formation in sputum of stable COPD patients
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Quercetin attenuates inflammation in cigarette smoke stimulated airway epithelial cells: Possible involvement of autophagy
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Cell composition of induced sputum in patients with uncontrolled asthma and its participation in the formation of cold airway hyperresponsiveness
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Involvement of ferroptosis in COPD pathogenesis
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
New anti-inflammatory activities of Alpha-1-Antitrypsin and their role in COPD
Source: Annual Congress 2005 - Protease-antiprotease revisited
Year: 2005
The role of the frizzled-8 receptor in COPD with chronic mucus hypersecretion
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept